DRUG AFFINITIES FOR THE AGONIST AND ANTAGONIST STATES OF THE OPIOID RECEPTOR

被引：5
作者：
CHENEY, BV
LAHTI, RA
BARSUHN, C
机构：
来源：
EUROPEAN JOURNAL OF PHARMACOLOGY | 1982年 / 77卷 / 04期
关键词：
D O I：
10.1016/0014-2999(82)90127-3
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：259 / 263
页数：5
相关论文
共 50 条
[41]   Peptidomimetics Exhibiting Mu Opioid Receptor (MOPr) Agonist/Delta Opioid Receptor (DOPr) Antagonist Activity as Novel Pain Therapeutics [J].
Griggs, Nicholas ;
Bender, Aaron ;
Gao, Chao ;
Anand, Jessica ;
Traynor, John ;
Mosberg, Henry .
FASEB JOURNAL, 2016, 30
[42]   Design and synthesis of novel bifunctional peptides as δ/μ opioid receptor agonist and NK-1 receptor antagonist [J].
Hong, Suk-Koo ;
Oh, Joon Seok ;
Davis, Peg ;
Ma, Shou-Wu ;
Vanderah, Todd W. ;
Yamamura, Henry, I ;
Lai, Josephine ;
Porreca, Frank ;
Hruby, Victor J. ;
Kim, Young Gyu .
JOURNAL OF PEPTIDE SCIENCE, 2008, 14 (08) :157-157
[43]   Cardiovascular responses to central administration of mu and kappa opioid receptor agonist and antagonist in rats [J].
Rao, SP ;
Dunbar, JC .
FASEB JOURNAL, 2003, 17 (04) :A112-A112
[44]   Rational drug design of δ opioid receptor agonist TAN-67 [J].
Nagase, H ;
Fujii, H .
JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN, 2006, 64 (04) :371-381
[45]   The effects of endocannabinoid receptor agonist anandamide and antagonist rimonabant on opioid analgesia and tolerance in rats [J].
Altun, Ahmet ;
Ozdemir, Ercan ;
Yildirim, Kemal ;
Gursoy, Sinan ;
Durmus, Nedim ;
Bagcivan, Ihsan .
GENERAL PHYSIOLOGY AND BIOPHYSICS, 2015, 34 (04) :433-440
[46]   The influence of μ-opioid receptor agonist and antagonist peptides on peripheral blood mononuclear cells (PBMCs) [J].
Fiedorowicz, E. ;
Jarmolowska, B. ;
Iwan, M. ;
Kostyra, E. ;
Obuchowicz, R. ;
Obuchowicz, M. .
PEPTIDES, 2011, 32 (04) :707-712
[47]   Mutagenesis of the mouse delta opioid receptor converts (-)-buprenorphine from a partial agonist to an antagonist [J].
Bot, G ;
Blake, AD ;
Li, SX ;
Reisine, T .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1998, 284 (01) :283-290
[48]   Development of a Bioavailable μ Opioid Receptor (MOPr) Agonist, δ Opioid Receptor (DOPr) Antagonist Peptide That Evokes Antinociception without Development of Acute Tolerance [J].
Mosberg, Henry I. ;
Yeomans, Larisa ;
Anand, Jessica P. ;
Porter, Vanessa ;
Sohczyk-Kojiro, Katarzyna ;
Traynor, John R. ;
Jutkiewicz, Emily M. .
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (07) :3148-3153
[49]   Designer Drug Efficacy: Application of Receptor Theory to Fixed-Proportion Mu-Opioid Agonist and Antagonist Mixtures in Rhesus Monkeys [J].
Banks, Matthew ;
Cornelissen, Jeremy ;
Rice, Kenner ;
Zhang, Yan ;
Negus, S. Stevens .
NEUROPSYCHOPHARMACOLOGY, 2017, 42 :S635-S636
[50]   DOPAMINE D-1 RECEPTOR AGONIST-INDUCED GROOMING IS BLOCKED BY THE OPIOID RECEPTOR ANTAGONIST NALOXONE [J].
STOESSL, AJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 259 (03) :301-303
12345